Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Idiopathic Short Stature: full-pipeline trial registry
3 of 5 indexed Idiopathic Short Stature trials are currently recruiting.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Idiopathic Short Stature: 5 US clinical trials tracked, 3 recruiting.
Idiopathic Short Stature is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is BioMarin Pharmaceutical, running 2 of these trials.
Enrollment posture brief
Registry condition idiopathic-short-stature
OPEN 3 | RECR 60% | LATE 2 | EARLY 2 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)
Idiopathic Short Stature lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Idiopathic Short Stature on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Idiopathic Short Stature is recruiting above its size-band peers.
3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Idiopathic Short Stature research.
BioMarin Pharmaceutical accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.
-
Typical Idiopathic Short Stature enrolment sits around 136 participants.
Median target enrolment is 136 among the 5 trials that report a genuine target (sentinel values excluded). 1 of those (20%) plan for fewer than 100 participants.
-
Idiopathic Short Stature research is mostly interventional.
4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
A Study to Assess Growth in Children With Idiopathic Short Stature
BioMarin Pharmaceutical
NCT06309979
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Ascendis Pharma A/S
NCT07221851
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
BioMarin Pharmaceutical
NCT06382155
Genotropin Study Assessing Use of Injection Pen
Pfizer
NCT00965484
Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers
Novo Nordisk A/S
NCT01401244
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Idiopathic Short Stature records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Idiopathic Short Stature trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Idiopathic Short Stature page
5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Idiopathic Short Stature trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- BioMarin Pharmaceutical sponsors the most Idiopathic Short Stature trials on record, review their full trial history before evaluating a specific study. See BioMarin Pharmaceutical's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Idiopathic Short Stature condition card totals 5 registered trials; most-linked intervention somatropin; top US site state Idaho. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.